Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antifection
    (1)
  • Drug Metabolite
    (1)
  • Influenza Virus
    (1)
  • Others
    (2)
Filter
Search Result
Results for "

oseltamivir acid

" in TargetMol Product Catalog
  • Inhibitor Products
    7
    TargetMol | Activity
  • Isotope products
    3
    TargetMol | inventory
  • Natural Products
    1
    TargetMol | natural
Oseltamivir acid
T5186187227-45-8
Oseltamivir acid (GS4071) is a potent influenza virus neuraminidase inhibitor and the prodrug of GS4071.
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited
Oseltamivir acid methyl ester hydrochloride
T60663L208720-78-9
Oseltamivir acid methyl ester hydrochloride is a precursor form of oseltamivir acid. Oseltamivir acid methyl ester is converted to oseltamivir acid converted by carboxylesterase 1 (CES1).
  • $50
In Stock
Size
QTY
Oseltamivir-d3 acid
TMIH-04111242184-43-5
Oseltamivir-d3 acid is a deuterated compound of Oseltamivir acid. Oseltamivir acid has a CAS number of 196618-13-0.
  • -$2
7-10 days
Size
QTY
Oseltamivir acid methyl ester
T60663208720-71-2
Oseltamivir acid methyl ester is a precursor form of oseltamivir acid, that converts to oseltamivir acid by carboxylesterase 1(CES1). Oseltamivir acid is the neuraminidase inhibitor and antiviral agent [1].
  • $98
35 days
Size
QTY
Oseltamivir-13C-d3 Acid
TMIJ-0071
Oseltamivir-13C-d3 Acid the 13C and deuterated compound of Oseltamivir Acid. Oseltamivir Acid has a CAS number of 187227-45-8. Oseltamivir acid (GS4071) is a potent influenza virus neuraminidase inhibitor and the prodrug of GS4071.
  • Inquiry Price
20 days
Size
QTY
Oseltamivir-d3 acid(3R,4S,5S)
TMIH-0412
Oseltamivir-d3 acid(3R,4S,5S) is a deuterated compound of Oseltamivir acid(3R,4S,5S).
  • $485
7-10 days
Size
QTY
Ganoderic acid Z
TN4108294674-09-2
The binding affinities of ganoderic acid DM and ganoderic acid Z (ΔGbind, -16.83 and-10.99 kcal mol-1) are comparable to that of current commercial drug oseltamivir (-23.62 kcal mol-1);Ganoderic acid DM is a potential source of anti-influenza ingredient, with novel binding pattern and advantage over oseltamivir, it has steric hindrance on the 150 cavity of N1 protein, and exerts activities across the H274Y and N294S mutations, is the attractive candidates of novel neuraminidase (NA) inhibitors.Ganoderic acid zeta has cytotoxicity in vitro against Meth-A and LLC cell lines.
  • $870
Backorder
Size
QTY
TargetMol | Inhibitor Sale